CompaniesByCap
USNA
Usana Health Sciences, Inc. (USNA)
NYSE · Consumer Defensive

Usana Health Sciences, Inc. Revenue 2016–2026

Usana Health Sciences, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Usana Health Sciences, Inc. revenue for the quarter ending April 4, 2026 was 250.2 M, a 0.75% increase year-over-year.
  • Usana Health Sciences, Inc. revenue for the twelve months ending April 4, 2026 was 949.3 M, a 11.12% increase year-over-year.
  • Usana Health Sciences, Inc. annual revenue for 2026 was 925.3 M, a 8.28% increase from 2024.
  • Usana Health Sciences, Inc. annual revenue for 2024 was 854.5 M, a 7.22% decrease from 2023.
  • Usana Health Sciences, Inc. annual revenue for 2023 was 921.0 M, a 7.77% decrease from 2022.
  • Usana Health Sciences, Inc. annual revenue for 2022 was 998.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Usana Health Sciences, Inc. (USNA) — Frequently Asked Questions

Usana Health Sciences, Inc. (USNA) is a publicly traded US company. It has a market capitalization of $356M. In fiscal 2026 it reported revenue of $925M and net income of $11M. Explore USNA's stock price, financial statements, earnings history, margins and key ratios below.

What is Usana Health Sciences, Inc.'s market cap?

Usana Health Sciences, Inc. (USNA) has a market capitalization of $356M.

What is the USNA stock price?

USNA trades at $19.17 (+0.84% on the day).

How much revenue does Usana Health Sciences, Inc. make?

Usana Health Sciences, Inc. reported revenue of $925M in fiscal 2026.

Is USNA profitable?

In fiscal 2026, Usana Health Sciences, Inc. reported net income of $11M.